MX360034B - Determinacion no invasiva del metiloma fetal o de tumor de plasma. - Google Patents
Determinacion no invasiva del metiloma fetal o de tumor de plasma.Info
- Publication number
- MX360034B MX360034B MX2015003571A MX2015003571A MX360034B MX 360034 B MX360034 B MX 360034B MX 2015003571 A MX2015003571 A MX 2015003571A MX 2015003571 A MX2015003571 A MX 2015003571A MX 360034 B MX360034 B MX 360034B
- Authority
- MX
- Mexico
- Prior art keywords
- methylation
- fetal
- tumor
- dna
- fetus
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 6
- 230000001605 fetal effect Effects 0.000 title abstract 3
- 230000011987 methylation Effects 0.000 abstract 10
- 238000007069 methylation reaction Methods 0.000 abstract 10
- 210000003754 fetus Anatomy 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 108700028369 Alleles Proteins 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2523/00—Reactions characterised by treatment of reaction samples
- C12Q2523/10—Characterised by chemical treatment
- C12Q2523/125—Bisulfite(s)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
- C12Q2535/122—Massive parallel sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Medical Informatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261703512P | 2012-09-20 | 2012-09-20 | |
| US13/842,209 US9732390B2 (en) | 2012-09-20 | 2013-03-15 | Non-invasive determination of methylome of fetus or tumor from plasma |
| US201361830571P | 2013-06-03 | 2013-06-03 | |
| PCT/AU2013/001088 WO2014043763A1 (en) | 2012-09-20 | 2013-09-20 | Non-invasive determination of methylome of fetus or tumor from plasma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015003571A MX2015003571A (es) | 2015-06-22 |
| MX360034B true MX360034B (es) | 2018-10-19 |
Family
ID=50340462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015003571A MX360034B (es) | 2012-09-20 | 2013-09-20 | Determinacion no invasiva del metiloma fetal o de tumor de plasma. |
Country Status (28)
| Country | Link |
|---|---|
| EP (6) | EP3536807B1 (enExample) |
| JP (6) | JP6317354B2 (enExample) |
| KR (5) | KR102390711B1 (enExample) |
| CN (2) | CN117757932A (enExample) |
| AU (5) | AU2013317708C1 (enExample) |
| BR (3) | BR112015006183B1 (enExample) |
| CA (2) | CA2884066C (enExample) |
| CY (1) | CY1124139T1 (enExample) |
| DK (4) | DK3536807T3 (enExample) |
| EA (1) | EA201500327A1 (enExample) |
| ES (4) | ES2862726T3 (enExample) |
| FI (2) | FI3536807T3 (enExample) |
| HR (3) | HRP20240210T1 (enExample) |
| HU (3) | HUE053822T2 (enExample) |
| IL (4) | IL299444B2 (enExample) |
| LT (2) | LT3354747T (enExample) |
| MX (1) | MX360034B (enExample) |
| MY (2) | MY187444A (enExample) |
| NZ (2) | NZ717423A (enExample) |
| PH (2) | PH12022552061A1 (enExample) |
| PL (4) | PL3536807T3 (enExample) |
| PT (4) | PT3354747T (enExample) |
| SG (2) | SG11201501927VA (enExample) |
| SI (1) | SI4056712T1 (enExample) |
| SM (1) | SMT202100256T1 (enExample) |
| TW (4) | TWI806621B (enExample) |
| WO (1) | WO2014043763A1 (enExample) |
| ZA (1) | ZA201501772B (enExample) |
Families Citing this family (94)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101153336B (zh) | 2006-09-27 | 2011-09-07 | 香港中文大学 | 检测dna甲基化程度的方法和试剂盒 |
| US9892230B2 (en) | 2012-03-08 | 2018-02-13 | The Chinese University Of Hong Kong | Size-based analysis of fetal or tumor DNA fraction in plasma |
| US9732390B2 (en) | 2012-09-20 | 2017-08-15 | The Chinese University Of Hong Kong | Non-invasive determination of methylome of fetus or tumor from plasma |
| BR112015006183B1 (pt) | 2012-09-20 | 2022-04-26 | The Chinese University Of Hong Kong | Métodos para analisar uma amostra biológica de um organismo, para determinar um primeiro perfil de metilação de uma amostra biológica de um organismo, para detecção de uma anormalidade cromossômica de uma amostra biológica de um organismo e para estimar um nível de metilação do dna em uma amostra biológica de um organismo, produto de computador, e, kit para análise de dna fetal |
| US10706957B2 (en) | 2012-09-20 | 2020-07-07 | The Chinese University Of Hong Kong | Non-invasive determination of methylome of tumor from plasma |
| US20130309666A1 (en) | 2013-01-25 | 2013-11-21 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| WO2015013885A1 (zh) * | 2013-07-30 | 2015-02-05 | 深圳华大基因科技有限公司 | 确定核酸混合物中核酸组成的方法 |
| US10174375B2 (en) | 2013-09-20 | 2019-01-08 | The Chinese University Of Hong Kong | Sequencing analysis of circulating DNA to detect and monitor autoimmune diseases |
| WO2015126840A1 (en) * | 2014-02-18 | 2015-08-27 | Bionano Genomics, Inc. | Improved methods of determining nucleic acid structural information |
| EP3561075A1 (en) * | 2014-04-21 | 2019-10-30 | Natera, Inc. | Detecting mutations in tumour biopsies and cell-free samples |
| US12492429B2 (en) | 2014-04-21 | 2025-12-09 | Natera, Inc. | Detecting mutations and ploidy in chromosomal segments |
| EP2942400A1 (en) | 2014-05-09 | 2015-11-11 | Lifecodexx AG | Multiplex detection of DNA that originates from a specific cell-type |
| CA2985134A1 (en) | 2014-05-09 | 2015-11-12 | Sebastian Gromminger | Detection of dna that originates from a specific cell-type and related methods |
| TWI727156B (zh) * | 2014-07-18 | 2021-05-11 | 香港中文大學 | Ｄｎａ混合物中之組織甲基化模式分析 |
| WO2016010401A1 (ko) * | 2014-07-18 | 2016-01-21 | 에스케이텔레콘 주식회사 | 산모의 혈청 dna를 이용한 태아의 단일유전자 유전변이의 예측방법 |
| EP4358097A1 (en) | 2014-07-25 | 2024-04-24 | University of Washington | Methods of determining tissues and/or cell types giving rise to cell-free dna, and methods of identifying a disease or disorder using same |
| EP4574996B1 (en) | 2014-12-31 | 2025-11-05 | Guardant Health, Inc. | Detection and treatment of disease exhibiting disease cell heterogeneity and systems and methods for communicating test results |
| US10364467B2 (en) * | 2015-01-13 | 2019-07-30 | The Chinese University Of Hong Kong | Using size and number aberrations in plasma DNA for detecting cancer |
| ES2908347T3 (es) | 2015-02-10 | 2022-04-28 | Univ Hong Kong Chinese | Detección de mutaciones para cribado de cáncer y análisis fetal |
| WO2017012544A1 (en) * | 2015-07-20 | 2017-01-26 | The Chinese University Of Hong Kong | Methylation pattern analysis of haplotypes in tissues in dna mixture |
| EP4279612B1 (en) * | 2015-07-23 | 2025-07-02 | The Chinese University of Hong Kong | Analysis of fragmentation patterns of cell-free dna |
| CA2995422A1 (en) | 2015-08-12 | 2017-02-16 | The Chinese University Of Hong Kong | Single-molecule sequencing of plasma dna |
| CN108026576B (zh) | 2015-09-22 | 2022-06-28 | 香港中文大学 | 通过母亲血浆dna的浅深度测序准确定量胎儿dna分数 |
| US10260088B2 (en) * | 2015-10-30 | 2019-04-16 | New England Biolabs, Inc. | Compositions and methods for analyzing modified nucleotides |
| CN108368548A (zh) * | 2015-11-09 | 2018-08-03 | 普罗格尼迪公司 | 用于确定dna分子的来源的方法 |
| EP3168309B8 (en) | 2015-11-10 | 2020-06-03 | Eurofins LifeCodexx GmbH | Detection of foetal chromosomal aneuploidies using dna regions that are differentially methylated between the foetus and the pregnant female |
| AU2016370835B2 (en) | 2015-12-17 | 2020-02-13 | Illumina, Inc. | Distinguishing methylation levels in complex biological samples |
| CN116640847A (zh) * | 2016-02-02 | 2023-08-25 | 夸登特健康公司 | 癌症进化检测和诊断 |
| US11514289B1 (en) | 2016-03-09 | 2022-11-29 | Freenome Holdings, Inc. | Generating machine learning models using genetic data |
| EP4425178A3 (en) | 2016-05-03 | 2024-12-18 | University Health Network | Methods of capturing cell-free methylated dna and uses of same |
| WO2017201606A1 (en) * | 2016-05-04 | 2017-11-30 | Queen's University At Kingston | Cell-free detection of methylated tumour dna |
| SG11201810544WA (en) | 2016-05-30 | 2018-12-28 | Univ Hong Kong Chinese | Detecting hematological disorders using cell-free dna in blood |
| WO2017218908A2 (en) * | 2016-06-16 | 2017-12-21 | The Johns Hopkins University | Methods and system for epigenetic analysis |
| US11999998B2 (en) | 2016-08-24 | 2024-06-04 | Center For Excellence In Molecular Cell Science, Chinese Academy Of Sciences | Modification of 5-methylcytosine catalyzed by Cmd1 enzyme and application thereof |
| EP3529377B1 (en) | 2016-10-19 | 2023-04-05 | The Chinese University Of Hong Kong | Gestational age assessment by methylation and size profiling of maternal plasma dna |
| WO2018081130A1 (en) | 2016-10-24 | 2018-05-03 | The Chinese University Of Hong Kong | Methods and systems for tumor detection |
| JP2020503003A (ja) * | 2016-11-30 | 2020-01-30 | ザ チャイニーズ ユニバーシティ オブ ホンコン | 尿および他のサンプルにおける無細胞ｄｎａの分析 |
| WO2018112100A2 (en) * | 2016-12-13 | 2018-06-21 | Bellwether Bio, Inc. | Determining a physiological condition in an individual by analyzing cell-free dna fragment endpoints in a biological sample |
| BR112019014208A2 (pt) * | 2017-01-11 | 2020-03-17 | Quest Diagnostics Investments Llc | Métodos para detectar diagnóstico falso-positivo de aneuploidia cromossômica em um feto e para detectar diagnóstico aneuploidiadiagnóstico de aneuploidia cromossômica falso-positiva em um feto. |
| PL3575407T3 (pl) * | 2017-01-24 | 2024-07-29 | Bgi Genomics Co., Ltd. | Sposób oznaczania udziału frakcji bezkomórkowych kwasów nukleinowych z wcześniej określonego źródła w próbce biologicznej |
| AU2018212272B2 (en) | 2017-01-25 | 2022-04-28 | Grail, Inc. | Diagnostic applications using nucleic acid fragments |
| CN107247873B (zh) * | 2017-03-29 | 2020-04-14 | 电子科技大学 | 一种差异甲基化位点识别方法 |
| CN111417731A (zh) * | 2017-05-12 | 2020-07-14 | 哈佛学院校长同事会 | 通用早期癌症诊断 |
| US12031184B2 (en) | 2017-07-12 | 2024-07-09 | University Health Network | Cancer detection and classification using methylome analysis |
| US12227737B2 (en) | 2017-07-12 | 2025-02-18 | University Health Network | Cancer detection and classification using methylome analysis |
| CN118782138A (zh) * | 2017-07-12 | 2024-10-15 | 安德股份有限公司 | 模式识别系统 |
| CN111051536A (zh) | 2017-07-26 | 2020-04-21 | 香港中文大学 | 利用不含细胞的病毒核酸改善癌症筛选 |
| WO2019055819A1 (en) | 2017-09-14 | 2019-03-21 | Grail, Inc. | METHODS FOR PREPARING A SEQUENCING LIBRARY FROM SINGLE STRANDED DNA |
| US11851650B2 (en) | 2017-09-28 | 2023-12-26 | Grail, Llc | Enrichment of short nucleic acid fragments in sequencing library preparation |
| US11168356B2 (en) * | 2017-11-02 | 2021-11-09 | The Chinese University Of Hong Kong | Using nucleic acid size range for noninvasive cancer detection |
| TW202434742A (zh) | 2018-03-13 | 2024-09-01 | 美商格瑞爾有限責任公司 | 異常片段偵測及分類 |
| KR20210023804A (ko) * | 2018-03-15 | 2021-03-04 | 그레일, 인코포레이티드. | 조직 특이적 메틸화 마커 |
| CN119753091A (zh) | 2018-04-02 | 2025-04-04 | 格里尔公司 | 用于扩增与癌症相关联的cfDNA分子的化验板 |
| AU2019253118B2 (en) * | 2018-04-13 | 2024-02-22 | Freenome Holdings, Inc. | Machine learning implementation for multi-analyte assay of biological samples |
| EP3781709A4 (en) * | 2018-04-16 | 2022-11-30 | Grail, LLC | Systems and methods for determining tumor fraction in cell-free nucleic acid |
| WO2019209884A1 (en) | 2018-04-23 | 2019-10-31 | Grail, Inc. | Methods and systems for screening for conditions |
| US11932899B2 (en) * | 2018-06-07 | 2024-03-19 | 10X Genomics, Inc. | Methods and systems for characterizing nucleic acid molecules |
| CN109448789A (zh) * | 2018-09-17 | 2019-03-08 | 上海派森诺生物科技股份有限公司 | 一种基于perl语言的种群特异SNP位点的自动化分析方法 |
| WO2020069350A1 (en) | 2018-09-27 | 2020-04-02 | Grail, Inc. | Methylation markers and targeted methylation probe panel |
| CN109295230A (zh) * | 2018-10-24 | 2019-02-01 | 福建翊善生物科技有限公司 | 一种基于ctDNA的多基因联合突变检测评估肿瘤动态变化的方法 |
| CN114901818B (zh) | 2018-11-21 | 2025-01-10 | 安捷伦科技有限公司 | 靶向核酸文库形成的方法 |
| ES2968457T3 (es) * | 2018-12-19 | 2024-05-09 | Univ Hong Kong Chinese | Características de los extremos del ADN extracelular circulante |
| US12234514B2 (en) | 2018-12-21 | 2025-02-25 | Grail, Inc. | Source of origin deconvolution based on methylation fragments in cell-free DNA samples |
| WO2020163410A1 (en) | 2019-02-05 | 2020-08-13 | Grail, Inc. | Detecting cancer, cancer tissue of origin, and/or a cancer cell type |
| EP4485464A3 (en) | 2019-02-05 | 2025-02-19 | Grail, Inc. | Detecting cancer, cancer tissue of origin, and/or a cancer cell type |
| TWI874374B (zh) | 2019-03-25 | 2025-03-01 | 香港中文大學 | 確定循環核酸之線性及環狀形式 |
| US11773450B2 (en) | 2019-04-03 | 2023-10-03 | Grail, Llc | Methylation-based false positive duplicate marking reduction |
| US20220243263A1 (en) * | 2019-05-03 | 2022-08-04 | Cornell University | Markers for identifying and quantifying of nucleic acid sequence mutation, expression, splice variant, translocation, copy number, or methylation changes |
| CA3147613A1 (en) * | 2019-08-19 | 2021-02-25 | Chang-Seok Ki | Method for detecting chromosomal abnormality by using information about distance between nucleic acid fragments |
| KR102452413B1 (ko) * | 2019-08-19 | 2022-10-11 | 주식회사 지씨지놈 | 핵산 단편간 거리 정보를 이용한 염색체 이상 검출 방법 |
| GB201915469D0 (en) | 2019-10-24 | 2019-12-11 | Univ London | Cancer detection methods |
| EP4066245A1 (en) * | 2019-11-27 | 2022-10-05 | Grail, LLC | Systems and methods for evaluating longitudinal biological feature data |
| EP4534690A3 (en) | 2020-01-31 | 2025-07-23 | Agilent Technologies, Inc. | Systems and methods for targeted nucleic acid capture |
| US20210247378A1 (en) * | 2020-02-10 | 2021-08-12 | Palogen, Inc. | Nanopore device and methods of detecting and classifying charged particles using same |
| US11211147B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing |
| US11475981B2 (en) | 2020-02-18 | 2022-10-18 | Tempus Labs, Inc. | Methods and systems for dynamic variant thresholding in a liquid biopsy assay |
| US11211144B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Methods and systems for refining copy number variation in a liquid biopsy assay |
| US20210292845A1 (en) * | 2020-02-28 | 2021-09-23 | Grail, Inc. | Identifying methylation patterns that discriminate or indicate a cancer condition |
| CN112662764A (zh) * | 2020-03-17 | 2021-04-16 | 博尔诚（北京）科技有限公司 | 一种检测11种癌症的探针组合物 |
| RU2738675C1 (ru) * | 2020-07-28 | 2020-12-15 | Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") | Способ прогнозирования риска развития преэклампсии у женщин без отягощенного семейного анамнеза с учетом генетических факторов |
| US20240026453A1 (en) * | 2020-11-19 | 2024-01-25 | Nucleix Ltd. | Detecting methylation changes in dna samples using restriction enzymes and high throughput sequencing |
| WO2022133315A1 (en) * | 2020-12-17 | 2022-06-23 | President And Fellows Of Harvard College | Methods of cancer detection using extraembryonically methylated cpg islands |
| CN112813148A (zh) * | 2021-02-02 | 2021-05-18 | 博淼生物科技（北京）有限公司 | 飞行时间质谱检测5-羟甲基胞嘧啶的方法 |
| EP4409468A4 (en) * | 2021-09-28 | 2025-08-13 | Act Genomics Ip Ltd | APPARATUS AND METHODS FOR SELECTING METHYLATION BIOMARKERS |
| KR20230059423A (ko) * | 2021-10-26 | 2023-05-03 | 주식회사 지씨지놈 | 메틸화된 무세포 핵산을 이용한 암 진단 및 암 종 예측방법 |
| US20230138633A1 (en) * | 2021-11-04 | 2023-05-04 | Universal Diagnostics, S.L. | Systems and methods for preparing biological samples for genetic sequencing |
| WO2023147783A1 (en) | 2022-02-07 | 2023-08-10 | Centre For Novostics Limited | Fragmentation for measuring methylation and disease |
| WO2023164017A2 (en) * | 2022-02-22 | 2023-08-31 | Flagship Pioneering Innovations Vi, Llc | Intra-individual analysis for presence of health conditions |
| CN115064211B (zh) * | 2022-08-15 | 2023-01-24 | 臻和(北京)生物科技有限公司 | 一种基于全基因组甲基化测序的ctDNA预测方法及装置 |
| CN115612723B (zh) * | 2022-09-26 | 2023-07-14 | 广州女娲生命科技有限公司 | 植入前胚胎的筛选方法 |
| WO2024203348A1 (ja) * | 2023-03-31 | 2024-10-03 | ソニーグループ株式会社 | 腫瘍の解析方法、腫瘍の解析システム、及び腫瘍の解析データ生成方法 |
| CN118737268A (zh) * | 2023-05-04 | 2024-10-01 | 杭州圣庭医疗科技有限公司 | 一种鉴定肿瘤组织来源的试剂盒的数据分析方法 |
| CN117025753A (zh) * | 2023-08-15 | 2023-11-10 | 广州女娲生命科技有限公司 | 检测染色体变异的方法和装置 |
| CN117079822B (zh) * | 2023-10-17 | 2024-01-02 | 北京大学第三医院（北京大学第三临床医学院） | 一种妊娠早中期四因子预测胎儿脑损伤的系统 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6927028B2 (en) | 2001-08-31 | 2005-08-09 | Chinese University Of Hong Kong | Non-invasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA |
| ES2253461T3 (es) | 2002-03-05 | 2006-06-01 | Epigenomics Ag | Procedimiento y dispositivo para la determinacion de la especificidad del tejido y del adn que flota libre en tejidos corporales. |
| AU2003294315A1 (en) * | 2002-11-19 | 2004-06-15 | Amgen Inc. | Amplified genes involved in cancer |
| US20060183128A1 (en) † | 2003-08-12 | 2006-08-17 | Epigenomics Ag | Methods and compositions for differentiating tissues for cell types using epigenetic markers |
| DE10348407A1 (de) | 2003-10-17 | 2005-05-19 | Widschwendter, Martin, Prof. | Prognostische und diagnostische Marker für Zell-proliferative Erkrankungen von Brustgeweben |
| CA2559209C (en) * | 2004-03-08 | 2016-06-07 | Rubicon Genomics, Inc. | Methods and compositions for generating and amplifying dna libraries for sensitive detection and analysis of dna methylation |
| AU2006251937A1 (en) | 2005-05-27 | 2006-11-30 | John Wayne Cancer Institute | Use of free circulating DNA for diagnosis, prognosis, and treatment of cancer |
| US7754428B2 (en) * | 2006-05-03 | 2010-07-13 | The Chinese University Of Hong Kong | Fetal methylation markers |
| US7901884B2 (en) * | 2006-05-03 | 2011-03-08 | The Chinese University Of Hong Kong | Markers for prenatal diagnosis and monitoring |
| CN101153336B (zh) * | 2006-09-27 | 2011-09-07 | 香港中文大学 | 检测dna甲基化程度的方法和试剂盒 |
| WO2008155549A2 (en) | 2007-06-19 | 2008-12-24 | Oncomethylome Sciences Sa | Improved urine sample collecting and processing |
| KR102458210B1 (ko) | 2007-07-23 | 2022-10-24 | 더 차이니즈 유니버시티 오브 홍콩 | 핵산 서열 불균형의 결정 |
| JP4347372B2 (ja) | 2007-08-10 | 2009-10-21 | トヨタ自動車株式会社 | 静電塗装装置 |
| US20110028333A1 (en) * | 2009-05-01 | 2011-02-03 | Brown University | Diagnosing, prognosing, and early detection of cancers by dna methylation profiling |
| US8563242B2 (en) * | 2009-08-11 | 2013-10-22 | The Chinese University Of Hong Kong | Method for detecting chromosomal aneuploidy |
| CA2775671A1 (en) † | 2009-10-02 | 2011-04-07 | Centre For Addiction And Mental Health | Method for analysis of dna methylation profiles of cell-free circulating dna in bodily fluids |
| LT3783110T (lt) * | 2009-11-05 | 2023-01-25 | The Chinese University Of Hong Kong | Vaisiaus genomo analizė iš motinos biologinio mėginio |
| US8620593B2 (en) | 2009-11-06 | 2013-12-31 | The Chinese University Of Hong Kong | Size-based genomic analysis |
| US10662474B2 (en) † | 2010-01-19 | 2020-05-26 | Verinata Health, Inc. | Identification of polymorphic sequences in mixtures of genomic DNA by whole genome sequencing |
| CN102892899A (zh) * | 2010-01-26 | 2013-01-23 | Nipd遗传学有限公司 | 无创产前诊断胎儿非整倍体性的方法和组合物 |
| CA3007805C (en) † | 2010-04-29 | 2019-11-26 | The Regents Of The University Of California | Pathway recognition algorithm using data integration on genomic models (paradigm) |
| GB201007944D0 (en) | 2010-05-12 | 2010-06-30 | Univ Aberystwyth | Methods |
| EP2576832B1 (en) | 2010-05-25 | 2016-05-04 | The Johns Hopkins University | Compositions and methods for detecting a neoplasia |
| WO2012012703A2 (en) * | 2010-07-23 | 2012-01-26 | Esoterix Genetic Laboratories, Llc | Identification of differentially represented fetal or maternal genomic regions and uses thereof |
| SG10201505723UA (en) * | 2010-07-23 | 2015-09-29 | Harvard College | Methods for detecting signatures of disease or conditions in bodily fluids |
| WO2012031329A1 (en) † | 2010-09-10 | 2012-03-15 | Murdoch Childrens Research Institute | Assay for detection and monitoring of cancer |
| EA038374B1 (ru) † | 2010-11-30 | 2021-08-17 | Те Чайниз Юниверсити Ов Гонконг | Способ анализа биологического образца организма для выявления хромосомных делеций или амплификаций, ассоциированных с раком |
| BR112015006183B1 (pt) | 2012-09-20 | 2022-04-26 | The Chinese University Of Hong Kong | Métodos para analisar uma amostra biológica de um organismo, para determinar um primeiro perfil de metilação de uma amostra biológica de um organismo, para detecção de uma anormalidade cromossômica de uma amostra biológica de um organismo e para estimar um nível de metilação do dna em uma amostra biológica de um organismo, produto de computador, e, kit para análise de dna fetal |
-
2013
- 2013-09-20 BR BR112015006183-4A patent/BR112015006183B1/pt active IP Right Grant
- 2013-09-20 CA CA2884066A patent/CA2884066C/en active Active
- 2013-09-20 KR KR1020217030373A patent/KR102390711B1/ko active Active
- 2013-09-20 ES ES17202149T patent/ES2862726T3/es active Active
- 2013-09-20 PT PT172021495T patent/PT3354747T/pt unknown
- 2013-09-20 EP EP19171630.7A patent/EP3536807B1/en active Active
- 2013-09-20 EP EP21151739.6A patent/EP3839065A1/en active Pending
- 2013-09-20 PT PT221714272T patent/PT4056712T/pt unknown
- 2013-09-20 EP EP17202149.5A patent/EP3354747B1/en not_active Revoked
- 2013-09-20 HU HUE17202149A patent/HUE053822T2/hu unknown
- 2013-09-20 WO PCT/AU2013/001088 patent/WO2014043763A1/en not_active Ceased
- 2013-09-20 MY MYPI2018000607A patent/MY187444A/en unknown
- 2013-09-20 PH PH1/2022/552061A patent/PH12022552061A1/en unknown
- 2013-09-20 IL IL299444A patent/IL299444B2/en unknown
- 2013-09-20 BR BR122021021825-0A patent/BR122021021825B1/pt active IP Right Grant
- 2013-09-20 EP EP24153604.4A patent/EP4335929A3/en active Pending
- 2013-09-20 MX MX2015003571A patent/MX360034B/es active IP Right Grant
- 2013-09-20 PL PL19171630.7T patent/PL3536807T3/pl unknown
- 2013-09-20 HU HUE22171427A patent/HUE068129T2/hu unknown
- 2013-09-20 JP JP2015532250A patent/JP6317354B2/ja active Active
- 2013-09-20 KR KR1020227013227A patent/KR102587176B1/ko active Active
- 2013-09-20 PL PL17202149T patent/PL3354747T3/pl unknown
- 2013-09-20 PH PH1/2015/500547A patent/PH12015500547B1/en unknown
- 2013-09-20 SM SM20210256T patent/SMT202100256T1/it unknown
- 2013-09-20 EA EA201500327A patent/EA201500327A1/ru unknown
- 2013-09-20 LT LTEP17202149.5T patent/LT3354747T/lt unknown
- 2013-09-20 CN CN202311671688.1A patent/CN117757932A/zh active Pending
- 2013-09-20 PT PT191716307T patent/PT3536807T/pt unknown
- 2013-09-20 CA CA3122779A patent/CA3122779A1/en active Pending
- 2013-09-20 HR HRP20240210TT patent/HRP20240210T1/hr unknown
- 2013-09-20 PL PL13838770.9T patent/PL2898100T5/pl unknown
- 2013-09-20 IL IL313451A patent/IL313451A/en unknown
- 2013-09-20 PT PT138387709T patent/PT2898100T/pt unknown
- 2013-09-20 FI FIEP19171630.7T patent/FI3536807T3/fi active
- 2013-09-20 ES ES13838770T patent/ES2665273T5/es active Active
- 2013-09-20 ES ES22171427T patent/ES2994426T3/es active Active
- 2013-09-20 PL PL22171427.2T patent/PL4056712T3/pl unknown
- 2013-09-20 CN CN201380058654.3A patent/CN104781422B/zh active Active
- 2013-09-20 EP EP22171427.2A patent/EP4056712B1/en active Active
- 2013-09-20 SG SG11201501927VA patent/SG11201501927VA/en unknown
- 2013-09-20 FI FIEP22171427.2T patent/FI4056712T3/fi active
- 2013-09-20 HR HRP20241142TT patent/HRP20241142T1/hr unknown
- 2013-09-20 LT LTEP22171427.2T patent/LT4056712T/lt unknown
- 2013-09-20 DK DK19171630.7T patent/DK3536807T3/da active
- 2013-09-20 SI SI201332088T patent/SI4056712T1/sl unknown
- 2013-09-20 KR KR1020157010184A patent/KR102148547B1/ko active Active
- 2013-09-20 AU AU2013317708A patent/AU2013317708C1/en active Active
- 2013-09-20 SG SG10201705198UA patent/SG10201705198UA/en unknown
- 2013-09-20 DK DK17202149.5T patent/DK3354747T3/da active
- 2013-09-20 NZ NZ717423A patent/NZ717423A/en unknown
- 2013-09-20 EP EP13838770.9A patent/EP2898100B9/en active Active
- 2013-09-20 HU HUE19171630A patent/HUE066054T2/hu unknown
- 2013-09-20 DK DK22171427.2T patent/DK4056712T3/da active
- 2013-09-20 KR KR1020237033920A patent/KR20230145530A/ko not_active Ceased
- 2013-09-20 ES ES19171630T patent/ES2969567T3/es active Active
- 2013-09-20 MY MYPI2015000628A patent/MY173356A/en unknown
- 2013-09-20 DK DK13838770.9T patent/DK2898100T4/da active
- 2013-09-20 BR BR122021021823-4A patent/BR122021021823B1/pt active IP Right Grant
- 2013-09-20 KR KR1020207019527A patent/KR102307424B1/ko active Active
- 2013-09-20 NZ NZ706269A patent/NZ706269A/en unknown
- 2013-09-23 TW TW111119079A patent/TWI806621B/zh active
- 2013-09-23 TW TW102134227A patent/TWI640634B/zh active
- 2013-09-23 TW TW107123815A patent/TWI707953B/zh active
- 2013-09-23 TW TW109112451A patent/TWI784258B/zh active
-
2015
- 2015-03-02 IL IL237495A patent/IL237495B/en active IP Right Grant
- 2015-03-16 ZA ZA2015/01772A patent/ZA201501772B/en unknown
-
2017
- 2017-10-27 AU AU2017251832A patent/AU2017251832B2/en active Active
-
2018
- 2018-03-28 JP JP2018061744A patent/JP6683752B2/ja active Active
-
2019
- 2019-08-05 IL IL268512A patent/IL268512B2/en unknown
-
2020
- 2020-01-08 AU AU2020200128A patent/AU2020200128B2/en active Active
- 2020-03-26 JP JP2020055387A patent/JP6985753B2/ja active Active
-
2021
- 2021-05-07 HR HRP20210716TT patent/HRP20210716T1/hr unknown
- 2021-05-14 CY CY20211100417T patent/CY1124139T1/el unknown
- 2021-11-18 JP JP2021188060A patent/JP2022031753A/ja active Pending
-
2022
- 2022-02-16 AU AU2022201026A patent/AU2022201026B2/en active Active
-
2023
- 2023-09-28 JP JP2023167714A patent/JP7594817B2/ja active Active
-
2024
- 2024-11-18 JP JP2024200780A patent/JP2025026936A/ja active Pending
-
2025
- 2025-07-03 AU AU2025205087A patent/AU2025205087A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX360034B (es) | Determinacion no invasiva del metiloma fetal o de tumor de plasma. | |
| MY205940A (en) | Gestational age assessment by methylation and size profiling of maternal plasma dna | |
| CY1118864T1 (el) | Μεθοδοι και συνθεσεις για μη επεμβατικη προγεννητικη διαγνωση εμβρυϊκων ανευπλοειδιων | |
| CY1123287T1 (el) | Αναλυση γονιδιωματικων κλασματων με χρηση των αριθμων πολυμορφισμων | |
| WO2013132305A8 (en) | Size-based analysis of fetal dna fraction in maternal plasma | |
| CO7151491A2 (es) | Método para la identificación del origen de un cancer de origen primario desconocido | |
| WO2012027402A3 (en) | Patient-matched instruments | |
| MX2017006670A (es) | Metodos y composiciones para la modificacion genetica dirigida mediante el uso de arn guia combinados. | |
| BR112014018331A8 (pt) | Biomarcadores e terapias combinadas usando vírus oncolítico e imunomodulação | |
| BR112015012295A8 (pt) | Uso de um inibidor de wee1, e, kit para identificar um paciente com câncer | |
| BR112015008708A2 (pt) | composição para clivagem de dna alvo compreendendo um rna guia específico para o dna alvo e ácido nucleico que codifica proteína cas ou proteína cas e uso da mesma | |
| BR112012022802A2 (pt) | uso de um inibidor de erbb3, e, método de supressão de crescimento de uma célula e de um tumor de câncer de mama | |
| EA201600044A1 (ru) | Композиции для интродукции рнк в клетки | |
| PH12020500156A1 (en) | Enhancement of cancer screening using cell-free viral nucleic acids | |
| BR112014011925A2 (pt) | mutações no receptor notch humano e seu uso | |
| AR090318A1 (es) | Lotes de adenovirus recombinantes con extremos terminales alterados | |
| BR112017016880A2 (pt) | métodos de avaliação genômica em gado | |
| CL2017001375A1 (es) | Métodos de monitoreo terapéutico de profármacos de ácido fenilacético. | |
| WO2015198334A3 (en) | Identification of cancer stem cell markers and use of same for diagnosis and treatment | |
| MX382589B (es) | Determinación no invasiva del metiloma fetal o de tumor de plasma. | |
| WO2019103421A3 (ko) | 유전자의 cpg 메틸화 변화를 이용한 간암의 예후 또는 위험도를 평가하는 방법 | |
| BR112015004279A2 (pt) | processos de polimerização usando componentes de reator suspensos em géis de hidrocarboneto | |
| JIANG et al. | Genotyping of human papillomavirus in male patients with anogenital warts in Lishui area, Zhejiang province | |
| Rossi et al. | In vitro effects of Plasmodium falciparum dihydrofolate reductase inhibitors on normal and cancer cell proliferation | |
| 野村綾菜 et al. | The Requirements for a Design of Raspatory's Grip |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |